| Literature DB >> 34931396 |
Akinobu Nishimura1,2, Makoto Ohtsuki3, Toshihiro Kato4, Rie Nagao-Nishiwaki5, Yoshiyuki Senga1, Ko Kato6, Toru Ogura7, Akihiro Sudo1,2.
Abstract
OBJECTIVES: Locomotion training (LT) consisting of single-leg standing and squatting was developed to help prevent locomotive syndrome (LS), and is typically used in older people. The objective of this study was to examine the effects of LT on young and middle-aged people.Entities:
Keywords: epidemiology; locomotion training; locomotive syndrome; young and middle adulthood
Mesh:
Year: 2021 PMID: 34931396 PMCID: PMC8689112 DOI: 10.1002/1348-9585.12303
Source DB: PubMed Journal: J Occup Health ISSN: 1341-9145 Impact factor: 2.708
FIGURE 1Flowchart of the study design and participant selection
Physical characteristics of each group
| Company A, | Company B, |
| |
|---|---|---|---|
| Sex (male/female) | 71/17 | 76/25 | .387 |
| Age (years) | 46.0 ± 7.4 | 46.9 ± 8.8 | .418 |
| Height (cm) | 168.0 ± 8.8 | 167.1 ± 8.2 | .460 |
| Weight (kg) | 65.3 ± 11.3 | 64.3 ± 9.7 | .511 |
| BMI (kg/m2) | 23.0 ± 2.6 | 23.0 ± 2.6 | .938 |
Data are expressed as the mean ± standard deviation for age, height, weight, and BMI. Differences in age, height, weight, and BMI between the two groups were analyzed for significance using an unpaired t‐test, and differences in sex were analyzed using Pearson's chi‐squared test.
Abbreviations: BMI, body mass index; n, number.
Comparison of locomotive syndrome (LS) stage and LS tests between baseline and follow‐up for both companies
| Company A ( | Company B ( | |||||
|---|---|---|---|---|---|---|
| Baseline | Follow‐up |
| Baseline | Follow‐up |
| |
| LS stage | ||||||
| Stage 0/1/2/3 | 67/20/1/0 | 80/6/2/0 | 88/11/2/0 | 84/15/2/0 | ||
| Median (IQR) | 0 (0–0) | 0 (0–0) | .022 | 0 (0–0) | 0 (0–0) | .32 |
| Two‐step test score | ||||||
| Mean ± SD | 1.66 ± 0.12 | 1.66 ± 0.11 | .822 | 1.65 ± 0.12 | 1.66 ± 0.12 | .064 |
| Stand‐up test | ||||||
| Median (IQR) | 6 (5–8) | 6 (5–8) | .012 | 6 (5–7) | 6 (5–8) | .042 |
| GLFS‐25 | ||||||
| Mean ± SD | 3.88 ± 3.54 | 2.72 ± 2.81 | .002 | 3.64 ± 5.30 | 3.28 ± 3.84 | .325 |
| Pain | ||||||
| Mean ± SD | 1.97 ± 2.21 | 1.59 ± 1.62 | .070 | 1.68 ± 1.90 | 1.63 ± 1.93 | .741 |
| Activities | ||||||
| Mean ± SD | 0.63 ± 1.11 | 0.42 ± 1.36 | .016 | 0.78 ± 2.50 | 0.57 ± 1.57 | .384 |
| Social functions | ||||||
| Mean ± SD | 1.09 ± 1.82 | 0.58 ± 1.21 | .003 | 0.86 ± 1.47 | 0.80 ± 1.38 | .716 |
| Mental health | ||||||
| Mean ± SD | 0.25 ± 0.58 | 0.13 ± 0.40 | .052 | 0.32 ± 0.87 | 0.27 ± 0.71 | .334 |
| Muscle strength (N) | ||||||
| Mean ± SD | 501.8 ± 132.5 | 525.4 ± 126.4 | .010 | 526.7 ± 128.7 | 518.0 ± 134.0 | .209 |
Abbreviations: GLFS‐25, 25‐question Geriatric Locomotive Function Scale; IQR, interquartile range; LS, locomotive syndrome; SD, standard deviation.
P < .01.
Comparison of locomotive syndrome (LS) stage and LS tests between baseline and follow‐up for workers with LS for both companies
| LS in Company A ( | LS in Company B ( | |||||
|---|---|---|---|---|---|---|
| Baseline | Follow‐up |
| Baseline | Follow‐up |
| |
| LS stage | ||||||
| Stage 0/1/2/3 | 0/20/1/0 | 16/5/0/0 | 0/11/2/0 | 5/6/2/0 | ||
| Median (IQR) | 1 (1–1) | 0 (0–0.5) | 1 (1–1) | 1 (0–1) | ||
| Two‐step test score | ||||||
| Mean ± SD | 1.63 ± 0.13 | 1.61 ± 0.10 | .210 | 1.63 ± 0.13 | 1.65 ± 0.12 | .228 |
| Stand‐up test | ||||||
| Median (IQR) | 5 (4–7.5) | 5 (5–8) | .059 | 5 (5–7) | 6 (5–8) | .683 |
| GLFS‐25 | ||||||
| Mean ± SD | 8.38 ± 3.75 | 4.67 ± 2.97 | .001 | 13.15 ± 9.92 | 9.31 ± 6.16 | .126 |
| Pain | ||||||
| Mean ± SD | 4.14 ± 2.87 | 2.33 ± 1.49 | .002 | 4.62 ± 2.18 | 4.08 ± 2.78 | .552 |
| Activities | ||||||
| Mean ± SD | 1.57 ± 1.63 | 1.00 ± 1.87 | .096 | 4.31 ± 5.88 | 2.38 ± 3.52 | .12 |
| Social functions | ||||||
| Mean ± SD | 2.24 ± 2.36 | 1.00 ± 1.58 | .008 | 2.77 ± 2.62 | 1.54 ± 1.98 | .041 |
| Mental health | ||||||
| Mean ± SD | 0.43 ± 0.81 | 0.33 ± 0.66 | .589 | 1.46 ± 1.85 | 1.31 ± 1.38 | .680 |
| Muscle strength (N) | ||||||
| Mean ± SD | 458.1 ± 105.6 | 482.3 ± 131.6 | .298 | 501.2 ± 125.0 | 506.7 ± 184.7 | .819 |
Abbreviations: GLFS‐25, 25‐question Geriatric Locomotive Function Scale; IQR, interquartile range; LS, locomotive syndrome; SD, standard deviation.
P < .01.
Comparison of locomotive syndrome (LS) stage and LS tests between baseline and follow‐up for workers without LS for both companies
| No LS in Company A ( | No LS in Company B ( | |||||
|---|---|---|---|---|---|---|
| Baseline | Follow‐up |
| Baseline | Follow‐up |
| |
| LS stage | ||||||
| Stage 0/1/2/3 | 67/0/0/0 | 64/1/2/0 | 88/0/0/0 | 79/9/0/0 | ||
| Median (IQR) | 0 (0–0) | 0 (0–0) | .102 | 0 (0–0) | 0 (0–0) | .003 |
| Two‐step test score | ||||||
| Mean ± SD | 1.67 ± 0.12 | 1.67 ± 0.11 | .395 | 1.65 ± 0.12 | 1.67 ± 0.12 | .106 |
| Stand‐up test | ||||||
| Median (IQR) | 6 (5–8) | 6 (5–8) | .065 | 6 (5–7) | 6 (5–8) | .031 |
| GLFS‐25 | ||||||
| Mean ± SD | 2.46 ± 1.91 | 2.10 ± 2.48 | .277 | 2.24 ± 1.81 | 2.39 ± 2.34 | .492 |
| Pain | ||||||
| Mean ± SD | 1.28 ± 1.40 | 1.36 ± 1.59 | .929 | 1.25 ± 1.42 | 1.27 ± 1.48 | .950 |
| Activities | ||||||
| Mean ± SD | 0.33 ± 0.66 | 0.24 ± 1.14 | .077 | 0.26 ± 0.56 | 0.31 ± 0.75 | .634 |
| Social functions | ||||||
| Mean ± SD | 0.73 ± 1.45 | 0.45 ± 1.05 | .092 | 0.58 ± 0.96 | 0.69 ± 1.24 | .498 |
| Mental health | ||||||
| Mean ± SD | 0.19 ± 0.47 | 0.06 ± 0.24 | .039 | 0.15 ± 0.42 | 0.11 ± 0.35 | .257 |
| Muscle strength (N) | ||||||
| Mean ± SD | 515.5 ± 137.8 | 539.0 ± 122.6 | .016 | 530.4 ± 129.5 | 519.6 ± 126.2 | .133 |
Abbreviations: GLFS‐25, 25‐question Geriatric Locomotive Function Scale; IQR, interquartile range; LS, locomotive syndrome; SD, standard deviation.
P < .01.
P < .05.